Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Frank Zycinski sold 1,200 shares of Plexus stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $140.84, for a total value of $169,008.00. Following the completion of the transaction, the insider now owns 723 shares in the company, valued at $101,827.32. This trade represents a 62.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Plexus Price Performance
Shares of NASDAQ PLXS traded down $1.46 during trading on Wednesday, hitting $139.37. 172,655 shares of the company were exchanged, compared to its average volume of 181,123. The firm’s fifty day moving average price is $157.54 and its 200 day moving average price is $144.24. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The company has a market cap of $3.77 billion, a price-to-earnings ratio of 32.34 and a beta of 0.89. Plexus Corp. has a 1 year low of $90.18 and a 1 year high of $172.89.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, sell-side analysts expect that Plexus Corp. will post 5.94 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Plexus
Wall Street Analyst Weigh In
A number of research firms recently weighed in on PLXS. KeyCorp assumed coverage on shares of Plexus in a research report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Stifel Nicolaus initiated coverage on shares of Plexus in a report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 target price on the stock. Benchmark reiterated a “buy” rating and set a $165.00 price target on shares of Plexus in a research note on Wednesday, January 22nd. StockNews.com upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, Needham & Company LLC boosted their target price on Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $163.00.
View Our Latest Stock Report on PLXS
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What Are Dividend Contenders? Investing in Dividend Contenders
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.